Newton Howard, Ph.D.
Chair & Founder
Dr. Newton Howard is the founder of ni2o, Inc., which is developing a novel, artificial-intelligence driven brain-computer interface to treat a wide range of debilitating neurological disorders and to improve cognitive and athletic performance. His career spans academia, the U.S. military and the private sector. A prolific scientific author and inventor, he is highly skilled in moving research from the lab to military and commercial applications, including technology you may use daily such as wireless hotspots, Google Earth and Google Translate.
Dr. Howard holds advanced degrees in Mathematics (Oxford), Cognitive Informatics (Sorbonne), Neurosurgery (Oxford) and a Doctorate of Medical Sciences (Sorbonne). He has made significant contributions to the fields of neuroscience, linguistics and national defense, including the Physics of Cognition (a mathematical framework for modeling complex medical, economic and security equilibriums), Intention Awareness (a theory for predictive modeling of naturalistic systems), Mood State Indicators (an algorithm to model mental processes involved in human speech to predict emotional states), ADAMA (a method of autonomously identifying and contextually understanding metaphors in language), the Functional Code Unit (a method for translating neurological signaling to logical data structures) and most recently, the Brain Code (a multivariate analytical model designed to extract emergent properties of the brain’s neuronal system).
Dr. Howard is a professor at Oxford and Georgetown. He directs the Computational Neurosciences Lab at Oxford and the Synthetic Intelligence Lab at MIT. He is the Founder of, and active Board member at C4ADS, a non-profit organization which is dedicated to providing data-driven analysis and evidence-based reporting on global conflict and transnational security issues.
Richard Wirt is a senior technology executive with over 40 years of experience in the computer industry. Dr. Wirt currently serves on several technical advisory boards for startups and investment companies. His prior experience was a Managing Director and General Partner at Oxantium Ventures and a senior fellow/Corporate Vice President of Intel Corp. from 1981 to 2007 where he started and grew a large worldwide software group responsible for supporting Intel chips, founded and managed the Intel Microprocessor research labs, and was a founding member of the Linux foundation and served on its board. He has made many successful worldwide investments, including 10 large acquisitions of software companies. Operating at the highest executive level, Dr. Wirt has also worked with Intel industry partners, such as Microsoft, Dell, Oracle, HP, IBM, NEC, Fujitsu, and Redhat, among others.
Sergey Kanareykin is an entrepreneur and technologist, with 18 years of experience spanning software development, research, early stage technology investments, and startup management. He was the Chief Technology Officer and is currently serving as a board director of C4ADS, a Washington DC-based nonprofit organization dedicated to providing analysis and reporting on global conflict and transnational security issues. As part of the executive team of Oxantium Ventures, he conducted technical due diligence on potential portfolio companies.
Over years, he has been a serial entrepreneur, involved in multiple companies, including serving as a CEO of Make a Mind, an incubator for medical and cognitive technologies.
In 2013 and 2014, Sergey was the Tech Lead of the Brain Sciences Foundation.
Seema A. Khan
Principal, The Seed Advisory Group LLC
At the heart of Seema A. Khan’s career, has been the belief that driving socio-economic impact is fundamental to making a difference for a better future. Across her public and private sector portfolio, she has actioned this philosophy at the forefront of change, bringing visions to life.
A recognized international executive her experience includes socio-economic development, treaty, IP monetization, legal, strategy, investment, and communication. Building collaboration across multi-organizational, multi-functional, and multi-cultural teams, her win-win philosophy has allowed her to create holistic ecosystem value regardless of subject matter. She focuses her service on education and knowledge as the priceless foundation of anyone’s journey to a better future.
She is a NY Bar qualified lawyer, with a BA from the American University’s School of International Service, a JD from the Chicago-Kent College of Law, and a Parker School Certificate from Columbia University Law School.
John began his career over 30 years ago as a stockbroker with Bear Stearns and Lehman Brothers where he honed his natural sales abilities. A decade later, John pursued his lifelong passion for technology and immersed himself in being on the leading edge of the technology that made Wall Street tick. In 1998, John fulfilled his vision by founding LiquidTrader, a high-performance professional trading platform that was acquired in 2003 by GlobalTec Solutions, a leading provider of real-time trading tools for individual investors. While at GlobalTec, in 2005 John became Splash Media’s first customer. John spent seven years at GlobalTec, including the last five as its president consistently growing it to record profitability. While at GlobalTec, John was also the Co-Founder of the first direct access exchange for retail investors in the Spot Forex market. Also, while at GlobalTec, John conceived and architected the first server-side rules based, automated trading platform for retail traders. These entities were ultimately sold to Ally Bank Financial.
John acquired Splash Media in 2013 with the passion and vision of transforming social media and digital marketing by using cutting-edge tools and analytics coupled with great creative.
He currently sits on the Board of Wipe out Kid’s Cancer, a non-profit dedicated to eradicating adolescent cancer. John previously served as a board member of the Samaritan Inn, a non-profit homeless shelter for five years and was a past member of YPO.
Bettering the Future of Brain Health
Want to keep up to date on all our latest research and activities? Sign up for our newsletter!